Literature DB >> 16142814

The psychological impact of screening for type 2 diabetes.

Marcel C Adriaanse1, Frank J Snoek.   

Abstract

Until recently, there was little empirical data regarding the psychological impact of screening for type 2 diabetes. There is now some progress in this area, as evidenced by emerging population based studies reporting on the effects of screening for type 2 diabetes on perceived health status and well-being. Recent studies from our own and other groups show that the diagnosis type 2 diabetes has no substantial adverse or positive effect on the participants' perceived health status and well-being after notification of the test result. Importantly, screening-detected type 2 diabetes patients beforehand perceive their risk for type 2 diabetes to be low, despite the presence of risk factors, such as obesity, hypertension and a family history, and overall report low levels of diabetes-related symptom distress. Yet, screening-detected type 2 diabetes patients were bothered more by symptoms of hyperglycaemia and fatigue in the first year following diagnosis type 2 diabetes than non-diabetics. On the basis of research to date, we conclude that screening for type 2 diabetes in the general population has no serious psychological side effects. Whether lack of emotional response to screening, is because of unawareness or indifference, needs further investigation. Future studies should be aiming towards a better understanding of how to raise the awareness and understanding of type 2 diabetes and its risk factors in high-risk individuals, while avoiding or minimizing negative effects, such as emotional distress and denial. The growing number of younger people developing type 2 diabetes warrants further research into labeling effects of an early diagnosis. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16142814     DOI: 10.1002/dmrr.590

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  23 in total

1.  Motivation and experiences of self-testers regarding tests for cardiovascular risk factors.

Authors:  Martine H P Ickenroth; Janaica E J Grispen; Gaby Ronda; Marloes Tacken; Geert-Jan Dinant; Nanne K de Vries; Trudy van der Weijden
Journal:  Health Expect       Date:  2011-10-28       Impact factor: 3.377

Review 2.  Pros and cons of screening for occult Cushing syndrome.

Authors:  Antoine Tabarin; Paul Perez
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

3.  Recommendations on screening for type 2 diabetes in adults.

Authors:  Kevin Pottie; Alejandra Jaramillo; Gabriela Lewin; Jim Dickinson; Neil Bell; Paula Brauer; Lesley Dunfield; Michel Joffres; Harminder Singh; Marcello Tonelli
Journal:  CMAJ       Date:  2012-10-16       Impact factor: 8.262

4.  How can we identify candidates at highest risk--to screen or not to screen?

Authors:  N C Barengo; J O Tuomilehto
Journal:  Herz       Date:  2016-05       Impact factor: 1.443

5.  Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening.

Authors:  D R Webb; K Khunti; B Srinivasan; L J Gray; N Taub; S Campbell; J Barnett; J Henson; S Hiles; A Farooqi; S J Griffin; N J Wareham; M J Davies
Journal:  Trials       Date:  2010-02-19       Impact factor: 2.279

6.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial.

Authors:  Theresa M Marteau; Eleanor Mann; A Toby Prevost; Joana C Vasconcelos; Ian Kellar; Simon Sanderson; Michael Parker; Simon Griffin; Stephen Sutton; Ann Louise Kinmonth
Journal:  BMJ       Date:  2010-05-13

Review 7.  Should we screen for emotional distress in type 2 diabetes mellitus?

Authors:  François Pouwer
Journal:  Nat Rev Endocrinol       Date:  2009-11-03       Impact factor: 43.330

8.  Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol.

Authors:  Eleanor Mann; A Toby Prevost; Simon Griffin; Ian Kellar; Stephen Sutton; Michael Parker; Simon Sanderson; Ann Louise Kinmonth; Theresa M Marteau
Journal:  BMC Public Health       Date:  2009-02-20       Impact factor: 3.295

9.  The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients.

Authors:  Justin B Echouffo-Tcheugui; Rebecca K Simmons; Kate M Williams; Roslyn S Barling; A Toby Prevost; Ann Louise Kinmonth; Nicholas J Wareham; Simon J Griffin
Journal:  BMC Public Health       Date:  2009-05-12       Impact factor: 3.295

10.  Are people with negative diabetes screening tests falsely reassured? Parallel group cohort study embedded in the ADDITION (Cambridge) randomised controlled trial.

Authors:  Charlotte A M Paddison; Helen C Eborall; Stephen Sutton; David P French; Joana Vasconcelos; A Toby Prevost; Ann-Louise Kinmonth; Simon J Griffin
Journal:  BMJ       Date:  2009-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.